ACE and hypoparathyroidism: As expected, at last visit, the use of drugs related to hypoparathyroidism was significantly higher in group H. However, the use of remaining drugs at last visit was similar in both groups, with the exception of a higher proportion of ACE inhibitor users in group NH (group (27.1 vs. 20.8%; P=0.031).